Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 348641 - 348660 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (L01EX14) entrectinib | Rozlytrek 200 mg | 90 stk, Boks, Kapsel, hard, 200 mg , Boks | Retail price with vat |
$0-0 |
$0-0 |
Cancer; Carcinoma, Non-Small-Cell Lung | OrifarmAS |
| Norway | (L01EX14) entrectinib | Rozlytrek 200 mg | 90 stk, Boks, Kapsel, hard, 200 mg , Boks | Retail price with vat |
$0-0 |
$0-0 |
Cancer; Carcinoma, Non-Small-Cell Lung | RocheRegistrationGmbH |
| Norway | (L01EX17) capmatinib | Tabrecta 150 mg | 120 stk, Blisterpakning, Tablett, filmdrasjert, 150 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisEuropharmLimited |
| Norway | (L01EX17) capmatinib | Tabrecta 200 mg | 120 stk, Blisterpakning, Tablett, filmdrasjert, 200 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisEuropharmLimited |
| Norway | (L01EX21) tepotinib | Tepmetko 225 mg | 60 stk, Blisterpakning, Tablett, filmdrasjert, 225 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | MerckEuropeB.V. |
| Norway | (L01FD01) trastuzumab | Herzuma 150 mg | 150 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 150 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | CelltrionHealthcareHungaryKft.(1) |
| Norway | (L01FD01) trastuzumab | Kanjinti 150 mg | 1 x 150 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 150 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AmgenEuropeB.V.(2) |
| Norway | (L01FD01) trastuzumab | Ontruzant 150 mg | 150 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 150 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | SamsungBioepisNLB.V. |
| Norway | (L01FD01) trastuzumab | Herzuma 420 mg | 420 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 420 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | CelltrionHealthcareHungaryKft.(1) |
| Norway | (L01FD01) trastuzumab | Kanjinti 420 mg | 1 x 420 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 420 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AmgenEuropeB.V.(2) |
| Norway | (L01FD01) trastuzumab | Ontruzant 420 mg | 420 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 420 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | SamsungBioepisNLB.V. |
| Norway | (L01FD01) trastuzumab | Zercepac 60 mg | 60 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 60 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Stomach Neoplasms | AccordHealthcareS.L.U. |
| Norway | (L01FE02) panitumumab | Vectibix 20 mg/ml | 1 x 5 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeB.V. |
| Norway | (L01FE02) panitumumab | Vectibix 20 mg/ml | 1 x 20 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeB.V. |
| Norway | (L01FG01) bevacizumab | Vegzelma 25 mg/ml | 1 x 16 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 25 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | CelltrionHealthcareHungaryKft. |
| Norway | (L01FG01) bevacizumab | Vegzelma 25 mg/ml | 1 x 4 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 25 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | CelltrionHealthcareHungaryKft. |
| Norway | (L01FG02) ramucirumab | Cyramza 10 mg/ml | 10 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 10 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms | EliLillyNederlandB.V. |
| Norway | (L01FG02) ramucirumab | Cyramza 10 mg/ml | 50 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 10 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms | EliLillyNederlandB.V. |
| Norway | (L01FX02) gemtuzumab ozogamicin | Mylotarg 5 mg | 5 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 5 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | PfizerEuropeMAEEIG(1) |
| Norway | (L01FX07) blinatumomab | Blincyto 38,5 mikrog | , Hetteglass, Pulver til konsentrat og oppløsning til infusjonsvæske, oppløsning, 38,5 mikrog , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | OrifarmAS |
Pages
